
The biotech industry is thriving with innovation, demand, adaptability, and technological improvements, displaying resilience. The biotech industry, fueled by groundbreaking discoveries in genetic engineering and personalized treatment, is likely to continue growing.
Therefore, it could be wise to own fundamentally strong biotech stocks Illumina, Inc. (ILMN), Innoviva, Inc. (INVA) and Puma Biotechnology, Inc. (PBYI).